Picture of Althea group logo

AGH Althea group Share Price

0.000.00%
au flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Momentum

Relative Strength (%)
1m+24.4%
3m+150.11%
6m+51.84%
1yr-5.49%
Volume Change (%)
10d/3m-28.23%
Price vs... (%)
52w High-11.11%
50d MA+41.76%
200d MA+61.32%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-456.1%
Return on Equity-213.12%
Operating Margin-101.35%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
30th Jun 202530th Jun 2026
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2025 / 2026

Blurred out image of Althea group EPS forecast chart

Profile Summary

Althea Group Holdings Limited is engaged in the manufacturing, sales and distribution of cannabis-based medicines and recreational cannabis products. The Company operates through two business units: Althea and Peak Processing Solutions. Althea, the Company’s pharmaceutical business, offers a comprehensive range of cannabis-based medicines which are made available to patients through prescription. Peak Processing Solutions, the Company’s recreational cannabis business, produces legal cannabis products purchased by adult consumers in retail stores. The Company operates in highly regulated and legal cannabis markets across the world, with burgeoning operations in North America, Europe and Australia. The Company’s segments include the international pharmaceutical segment (Pharmaceutical Cannabis), the Canadian recreational segment (Recreational Cannabis) and the shared corporate services (Corporate).

Directors

Last Annual
June 30th, 2024
Last Interim
June 30th, 2024
Incorporated
June 21st, 2018
Public Since
September 21st, 2018
No. of Shareholders
9,242
Sector
Pharmaceuticals
Industry
Healthcare
Exchange
au flag iconAustralian Stock Exchange - SEATS
Shares in Issue
406,503,376

AGH Share Price Performance

Upcoming Events for AGH

Althea Group Holdings Ltd Extraordinary Shareholders Meeting

Althea Group Holdings Ltd Annual Shareholders Meeting

Half Year 2025 Althea Group Holdings Ltd Earnings Release

Similar to AGH

Picture of Acrux logo

Acrux

au flag iconAustralian Stock Exchange - SEATS

Picture of AFT Pharmaceuticals logo

AFT Pharmaceuticals

au flag iconAustralian Stock Exchange - SEATS

Picture of Anatara Lifesciences logo

Anatara Lifesciences

au flag iconAustralian Stock Exchange - SEATS

Picture of Argent BioPharma logo

Argent BioPharma

au flag iconAustralian Stock Exchange - SEATS

Picture of Biome Australia logo

Biome Australia

au flag iconAustralian Stock Exchange - SEATS

FAQ